Inventor · disambiguated record
Matthew J. Ellis
Also filed as: ELLIS MATTHEW · ELLIS MATTHEW J · ELLIS MATTHEW JOHN
5 granted patents·17 pending applications·21 citations·filing 2006–2023
77Inventor score
Files withUNIV NORTH CAROLINA CHAPEL HILL4BAYLOR COLLEGE MEDICINE3PEROU CHARLES M3UNIV NORTH CAROLINA3COOPERVISION INT LTD2
Top patents by PatentIndex Score
22 records- 0187US11649099B2Contact lens packages and methods of useCOOPERVISION INT LTD·Filed 2021·Granted May 16, 2023·4 cites·19 claims
- 0285US9631239B2Method of classifying a breast cancer instrinsic subtypePEROU CHARLES M·Filed 2009·Granted Apr 25, 2017·8 cites·9 claims
- 0379US2023250484A1Gene expression profiles to predict breast cancer outcomesUNIV NORTH CAROLINA CHAPEL HILL·Filed 2023·Application pending·0 cites
- 0477US9066963B2Methods of treating breast cancer with anthracycline therapyPEROU CHARLES M·Filed 2012·Granted Jun 30, 2015·4 cites·12 claims
- 0576US2022213563A1Gene expression profiles to predict breast cancer outcomesUNIV NORTH CAROLINA CHAPEL HILL·Filed 2022·Application pending·0 cites
- 0674US9181588B2Methods of treating breast cancer with taxane therapyPEROU CHARLES M·Filed 2012·Granted Nov 10, 2015·5 cites·20 claims
- 0774US2023272476A1Nano46 genes and methods to predict breast cancer outcomeVERACYTE INC·Filed 2022·Application pending·0 cites
- 0871US2019264290A1Gene expression profiles to predict breast cancer outcomesUNIV NORTH CAROLINA CHAPEL HILL·Filed 2019·Application pending·0 cites
- 0970US2020040407A1Gene expression profiles to predict breast cancer outcomesUNIV NORTH CAROLINA CHAPEL HILL·Filed 2019·Application pending·0 cites
- 1067US11945632B2Contact lens packages and methods of useCOOPERVISION INT LTD·Filed 2023·Granted Apr 2, 2024·0 cites·14 claims
- 1165US2014087959A1Methods And Compositions Involving Intrinsic GenesUNIV WASHINGTON·Filed 2013·Application pending·0 cites
- 1264US2009299640A1Methods and Compositions Involving Intrinsic GenesUNIV UTAH RES FOUND·Filed 2006·Application pending·0 cites
- 1363US2020332368A1Nano46 genes and methods to predict breast cancer outcomeVERACYTE INC·Filed 2020·Application pending·0 cites
- 1463US2025154597A1Transcriptional reprogramming differentiates active from inactive esr1 fusions in endocrine therapy-refractory metastatic breast cancerBAYLOR COLLEGE MEDICINE·Filed 2022·Application pending·0 cites
- 1560US2016153051A1Gene expression profiles to predict breast cancer outcomesUNIV NORTH CAROLINA·Filed 2015·Application pending·0 cites
- 1660US2016168645A1Gene expression profiles to predict breast cancer outcomesUNIV NORTH CAROLINA·Filed 2015·Application pending·0 cites
- 1757US2017044618A1Methods and compositions involving intrinsic genesUNIV WASHINGTON·Filed 2016·Application pending·0 cites
- 1852US2022249476A1MutL LOSS PREDICTS SENSITIVITY TO CDK4/6 INHIBITORS IN CANCERBAYLOR COLLEGE MEDICINE·Filed 2019·Application pending·0 cites
- 1947US2022326241A1Proteogenomic methods for diagnosing cancerBAYLOR COLLEGE MEDICINE·Filed 2020·Application pending·0 cites
- 2041US2015072021A1Methods and Kits for Predicting Outcome and Methods and Kits for Treating Breast Cancer with Radiation TherapyBRITISH COLUMBIA CANCER AGENCY·Filed 2014·Application pending·0 cites
- 2139US2015252440A1Methods of Treating Breast Cancer with Anthracycline TherapyUNIV NORTH CAROLINA·Filed 2015·Application pending·0 cites
- 2235US2016017438A1Methods of treating breast cancer with taxane therapyUNIV UTAH RES FOUND·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Matthew J. Ellis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →